These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 11550123)

  • 41. West Nile virus infection induces susceptibility of in vitro outgrown murine blastocysts to specific lysis by paternally directed allo-immune and virus-immune cytotoxic T cells.
    King NJ; Mullbacher A; Tian L; Rodger JC; Lidbury B; Hla RT
    J Reprod Immunol; 1993 Mar; 23(2):131-44. PubMed ID: 8510076
    [TBL] [Abstract][Full Text] [Related]  

  • 42. T cell epitope mapping of the e-protein of West Nile virus in BALB/c mice.
    De Filette M; Chabierski S; Andries O; Ulbert S; Sanders NN
    PLoS One; 2014; 9(12):e115343. PubMed ID: 25506689
    [TBL] [Abstract][Full Text] [Related]  

  • 43. DNA vaccines encoding interleukin-8 and RANTES enhance antigen-specific Th1-type CD4(+) T-cell-mediated protective immunity against herpes simplex virus type 2 in vivo.
    Sin J; Kim JJ; Pachuk C; Satishchandran C; Weiner DB
    J Virol; 2000 Dec; 74(23):11173-80. PubMed ID: 11070014
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vitro T-cell proliferative response to the flavivirus, west Nile.
    Kulkarni AB; Mullbacher A; Blanden RV
    Viral Immunol; 1991; 4(2):73-82. PubMed ID: 1722099
    [TBL] [Abstract][Full Text] [Related]  

  • 45. West Nile virus-induced neuroinflammation: glial infection and capsid protein-mediated neurovirulence.
    van Marle G; Antony J; Ostermann H; Dunham C; Hunt T; Halliday W; Maingat F; Urbanowski MD; Hobman T; Peeling J; Power C
    J Virol; 2007 Oct; 81(20):10933-49. PubMed ID: 17670819
    [TBL] [Abstract][Full Text] [Related]  

  • 46. DNA immunization circumvents deficient induction of T helper type 1 and cytotoxic T lymphocyte responses in neonates and during early life.
    Martinez X; Brandt C; Saddallah F; Tougne C; Barrios C; Wild F; Dougan G; Lambert PH; Siegrist CA
    Proc Natl Acad Sci U S A; 1997 Aug; 94(16):8726-31. PubMed ID: 9238045
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The primary in vivo murine cytotoxic T cell response to the flavivirus, West Nile.
    Kesson AM; Blanden RV; Mullbacher A
    J Gen Virol; 1987 Jul; 68 ( Pt 7)():2001-6. PubMed ID: 3496425
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Toxicological safety evaluation of DNA plasmid vaccines against HIV-1, Ebola, Severe Acute Respiratory Syndrome, or West Nile virus is similar despite differing plasmid backbones or gene-inserts.
    Sheets RL; Stein J; Manetz TS; Andrews C; Bailer R; Rathmann J; Gomez PL
    Toxicol Sci; 2006 Jun; 91(2):620-30. PubMed ID: 16569728
    [TBL] [Abstract][Full Text] [Related]  

  • 49. TLR9-targeted biodegradable nanoparticles as immunization vectors protect against West Nile encephalitis.
    Demento SL; Bonafé N; Cui W; Kaech SM; Caplan MJ; Fikrig E; Ledizet M; Fahmy TM
    J Immunol; 2010 Sep; 185(5):2989-97. PubMed ID: 20660705
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A West Nile virus NS4B-P38G mutant strain induces cell intrinsic innate cytokine responses in human monocytic and macrophage cells.
    Xie G; Luo H; Tian B; Mann B; Bao X; McBride J; Tesh R; Barrett AD; Wang T
    Vaccine; 2015 Feb; 33(7):869-78. PubMed ID: 25562791
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Splenic macrophages are required for protective innate immunity against West Nile virus.
    Bryan MA; Giordano D; Draves KE; Green R; Gale M; Clark EA
    PLoS One; 2018; 13(2):e0191690. PubMed ID: 29408905
    [TBL] [Abstract][Full Text] [Related]  

  • 52. West Nile virus T-cell ligand sequences shared with other flaviviruses: a multitude of variant sequences as potential altered peptide ligands.
    Jung KO; Khan AM; Tan BY; Hu Y; Simon GG; Nascimento EJ; Lemonnier F; Brusic V; Miotto O; Tan TW; Marques ET; Dhalia R; Salmon J; August JT
    J Virol; 2012 Jul; 86(14):7616-24. PubMed ID: 22573867
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identification of CD8+ T cell epitopes in the West Nile virus polyprotein by reverse-immunology using NetCTL.
    Larsen MV; Lelic A; Parsons R; Nielsen M; Hoof I; Lamberth K; Loeb MB; Buus S; Bramson J; Lund O
    PLoS One; 2010 Sep; 5(9):e12697. PubMed ID: 20856867
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Biodistribution of DNA plasmid vaccines against HIV-1, Ebola, Severe Acute Respiratory Syndrome, or West Nile virus is similar, without integration, despite differing plasmid backbones or gene inserts.
    Sheets RL; Stein J; Manetz TS; Duffy C; Nason M; Andrews C; Kong WP; Nabel GJ; Gomez PL
    Toxicol Sci; 2006 Jun; 91(2):610-9. PubMed ID: 16569729
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [DNA vaccine].
    Sato Y
    Rinsho Byori; 2001 Jul; 49(7):669-72. PubMed ID: 11519128
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [DNA vaccination--current status and future prospect--a new approach for controlling infectious diseases].
    Sasaki S; Fukushima J; Okuda K
    Nihon Saikingaku Zasshi; 1998 May; 53(2):407-24. PubMed ID: 9654941
    [No Abstract]   [Full Text] [Related]  

  • 57. Biophotonics and immune responses-Highlights from a new SPIE photonics west conference (BIOS 2006).
    Chen WR; Huang Z
    Photodiagnosis Photodyn Ther; 2006 Sep; 3(3):184-9. PubMed ID: 25049153
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Protection against dengue disease by synthetic nucleic acid antibody prophylaxis/immunotherapy.
    Flingai S; Plummer EM; Patel A; Shresta S; Mendoza JM; Broderick KE; Sardesai NY; Muthumani K; Weiner DB
    Sci Rep; 2015 Jul; 5():12616. PubMed ID: 26220099
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Engineered DNA Vaccination against Follicle-Stimulating Hormone Receptor Delays Ovarian Cancer Progression in Animal Models.
    Perales-Puchalt A; Wojtak K; Duperret EK; Yang X; Slager AM; Yan J; Muthumani K; Montaner LJ; Weiner DB
    Mol Ther; 2019 Feb; 27(2):314-325. PubMed ID: 30554854
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Assay Challenges for Emerging Infectious Diseases: The Zika Experience.
    Roberts CC; Maslow JN
    Vaccines (Basel); 2018 Oct; 6(4):. PubMed ID: 30279372
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.